Update in native tissue vaginal vault prolapse repair

Int Urogynecol J. 2020 Oct;31(10):2003-2010. doi: 10.1007/s00192-020-04368-4. Epub 2020 Jun 18.

Abstract

The lifetime risk of women for undergoing surgery for pelvic organ prolapse (POP) is estimated to be 11-19%, and 30% of these women will require subsequent reoperation over time. Following hysterectomy, 3.6 per 1,000 person-years need surgical correction of prolapse, and in two-thirds of these cases multi-compartment prolapse is present. In the last decades, vaginally synthetic meshes were widely used in pelvic reconstructive surgery. However, after the decision of the Food and Drug Administration in 2019 to stop selling all surgical mesh devices for transvaginal prolapse repair, native tissue (NT) vaginal repair seems to regain an important role in pelvic reconstructive surgery. In the literature, various surgical techniques have been described for apical repair, but the best surgical approach is still to be proven. This paper analyzes the current evidence from recent literature on NT vaginal vault prolapse (VVP) repair, with special focus on the safety and efficacy of the various vaginal techniques.

Keywords: Apical prolapse; Native tissue repair; Pelvic organ prolapse; Sacrocolpopexy; Transvaginal mesh; Vaginal vault prolapse.

MeSH terms

  • Female
  • Gynecologic Surgical Procedures
  • Humans
  • Hysterectomy
  • Pelvic Organ Prolapse* / surgery
  • Surgical Mesh / adverse effects
  • Vagina / surgery